We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CSGP:NASDAQCoStar Group, Inc. Analysis

Data as of 2026-03-10 - not real-time

$46.19

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

CoStar Group (CSGP) is trading around $46, which sits below its 20‑day SMA of $47.26 and well under the 50‑day SMA of $56.16, indicating short‑term weakness. The RSI of 38 points to bearish momentum, while the MACD line remains negative despite a bullish histogram, confirming a bearish technical outlook. Volume is on a decreasing trend and 30‑day volatility is extremely high at over 70%, adding to short‑term uncertainty. Fundamental metrics are stark: a trailing PE of 2,309 dwarfs the industry average of 33, and the discounted cash‑flow fair value of roughly $14 suggests the stock is severely overvalued. The market’s sentiment index shows “Extreme Greed,” yet the underlying valuation gap creates a substantial risk of correction.
Recent material news includes a Q4 earnings beat with 27% revenue growth, strong insider buying by the CEO and other executives, and upgrades from BTIG and Jefferies to “Buy,” which provide a modest bullish catalyst. Conversely, Jim Cramer’s AI‑related concerns and the stock’s 27% drop in February highlight lingering market skepticism. Analyst consensus remains “Buy” with a median price target near $65, implying a potential upside but still far above intrinsic estimates. The combination of bearish technical signals, high volatility, and a massive valuation premium suggests caution, especially for short‑term traders.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below 20‑day and 50‑day SMAs
  • Bearish RSI and MACD momentum
  • High volatility and decreasing volume

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong revenue growth and earnings beat
  • Analyst upgrades and insider buying support
  • Persistent overvaluation relative to DCF

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Massive PE disparity versus industry
  • DCF fair value far below current price
  • Sustained bearish technical trend and volatility

Key Metrics & Analysis

Financial Health

Revenue Growth26.90%
Profit Margin0.22%
P/E Ratio2309.5
ROE0.09%
ROA-0.34%
Debt/Equity13.67
P/B Ratio2.3
Op. Cash Flow$430.0M
Free Cash Flow$143.8M
Industry P/E33.1

Technical Analysis

TrendBearish
RSI38.1
Support$43.16
Resistance$52.35
MA 20$47.26
MA 50$56.16
MA 200$73.83
MACDBullish
VolumeDecreasing
Fear & Greed Index78.66

Valuation

Fair Value$14.05
Target Price$65.42
Upside/Downside41.63%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.89
Volatility70.11%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.